Soluble inflammatory markers as predictors of hepatocellular damage and therapeutic response in chronic hepatitis C

AUTOR(ES)

Moura, Alexandre Sampaio, Carmo, Ricardo Andrade, Teixeira, Antonio Lucio, Rocha, Manoel Otávio da Costa

FONTE

Brazilian Journal of Infectious Diseases

DATA DE PUBLICAÇÃO

2009-10

RESUMO

Hepatitis C is an important burden worldwide being an important cause of cirrhosis and liver cancer in different parts of the world. Host immune response, especially T helper type 1 (Th1) cell-mediated, seems to play an important role in disease progression but is also crucial for viral elimination following specific therapy. Immune activation can be evaluated using peripheral levels of different cytokines, such as different chemokines (e.g. CCL5, CXCL10) and tumor necrosis factor alpha (TNF-α), and their soluble receptors (e.g. soluble TNF-α receptors 1 (sTNF-R1) and 2 (sTNF-R2). This review article focuses on the potential use of peripheral inflammatory markers as predictors of liver histological changes and therapeutic response among patients with chronic hepatitis C.

Documentos Relacionados

• Soluble inflammatory markers as predictors of virological response in patients with chronic hepatitis C virus infection treated with interferon-α plus ribavirin
• Hepatitis C: a critical analysis of therapeutic response predictors
• Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
• Response predictors to treatment with pegylated interferon in chronic hepatitis B
• Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population.